Your Reliable Service Provider for Safety Assessment.
GeneWerk provides susceptible molecular platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments in minimal tissue samples down to the single-cell level. GeneWerk’s two decades of expertise in vector safety assessment, vector integration profiling, and clonality assessment in pre-and clinical gene/cell therapy clinical studies, as well as GCP/GCLP compliant services, enabled us to support our customers for their successful Gene Therapy. CAR-T drug approval and marketing authorization!
Brands: Integration site analysis, Gene-editing on/off-targets analysis, TCR/BCR repertoire, VCN, RCL/RCR, vector impurities detection, Next Generation Sequencing.